These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12360229)

  • 1. Genetics and market forces.
    Caulfield T
    Nat Rev Genet; 2002 Oct; 3(10):734. PubMed ID: 12360229
    [No Abstract]   [Full Text] [Related]  

  • 2. Actor-network theory: a tool to support ethical analysis of commercial genetic testing.
    Williams-Jones B; Graham JE
    New Genet Soc; 2003 Dec; 22(3):271-96. PubMed ID: 15115034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commercialization of genetic testing services: the FDA, market forces, and biological tarot cards.
    Malinowski MJ; Blatt RJ
    Tulane Law Rev; 1997 Mar; 71(4):1211-312. PubMed ID: 15744901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whither morality in genetic tests?
    Burgess MM
    Health Law Rev; 2001; 9(3):3-9. PubMed ID: 15706713
    [No Abstract]   [Full Text] [Related]  

  • 5. What's in a test?
    Nat Methods; 2009 Nov; 6(11):783. PubMed ID: 19885990
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethics and human genetics.
    Chapman AR
    Annu Soc Christ Ethics; 1998; 18():293-303. PubMed ID: 12528716
    [No Abstract]   [Full Text] [Related]  

  • 7. Creating needs? A review of survey data and concerns relevant to the commercialization of genetic testing.
    Caulfield T; Wertz D
    Community Genet; 2001; 4(2):68-76. PubMed ID: 12751481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Private genetic testing in Canada: a summary.
    Williams-Jones B
    Health Law Rev; 2001; 9(3):10-3. PubMed ID: 15706712
    [No Abstract]   [Full Text] [Related]  

  • 9. Survey confirms fears about licensing of genetic tests.
    Schissel A; Merz JF; Cho MK
    Nature; 1999 Nov; 402(6758):118. PubMed ID: 10646997
    [No Abstract]   [Full Text] [Related]  

  • 10. Social contract theory and just decision making: lessons from genetic testing for the BRCA mutations.
    Williams-Jones B; Burgess MM
    Kennedy Inst Ethics J; 2004 Jun; 14(2):115-42. PubMed ID: 15281186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Are we threatened by misuse? Discreditation of medical genetics].
    Goetz P; Foretová L; Macek M; Brdicka R; Jüttnerová V; Franková V; Horínová V; Payne J; Hach P
    Cas Lek Cesk; 2008; 147(3):159-61. PubMed ID: 18401982
    [No Abstract]   [Full Text] [Related]  

  • 12. The informed gatekeeper?: a commentary on genetic tests, marketing pressure and the role of primary care physicians.
    Caulfield TA
    Health Law Rev; 2001; 9(3):14-8. PubMed ID: 15706711
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethics and genetics in Latin America.
    Rivera-Lopez E
    Dev World Bioeth; 2002 May; 2(1):11-20. PubMed ID: 12872766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitfalls of genetic testing.
    Hubbard R; Lewontin RC
    N Engl J Med; 1996 May; 334(18):1192-4. PubMed ID: 8602190
    [No Abstract]   [Full Text] [Related]  

  • 15. A conceptual framework for genetic policy: comparing the medical, public health, and fundamental rights models.
    Andrews LB
    Wash Univ Law Q; 2001; 79(152):221-85. PubMed ID: 16211786
    [No Abstract]   [Full Text] [Related]  

  • 16. From innovation to successful commercialization: assessing value and investment--does the equation make sense?
    Toneguzzo F
    Surgery; 2008 Feb; 143(2):165-8. PubMed ID: 18242328
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic testing policy issues for the next millennium: abstract of remarks.
    Organization for Economic Cooperation and Development (OECD)
    J Biolaw Bus; 2001; 4(3):37-50. PubMed ID: 12962104
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene patenting--diagnosing the problem.
    Lancet Neurol; 2002 Sep; 1(5):267. PubMed ID: 12849409
    [No Abstract]   [Full Text] [Related]  

  • 19. [From intellectual property to commercial property].
    Cappelaere P
    Bull Cancer; 2005 Apr; 92(4):297-8. PubMed ID: 15888384
    [No Abstract]   [Full Text] [Related]  

  • 20. An ethical assessment framework for addressing global genetic issues in clinical practice.
    Cassells JM; Jenkins J; Lea DH; Calzone K; Johnson E
    Oncol Nurs Forum; 2003; 30(3):383-90. PubMed ID: 12719739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.